Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Metformin Treatment Report
What is Metformin?

Metformin an antidiabetic agent used for the management of type 2 diabetes mellitus (noninsulin dependent, NIDDM) as monotherapy when hyperglycemia (high blood sugar) cannot be managed with diet and exercise alone.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Diabetes Type II (non-insulin dependent) 10 0
Other 10 1
General health 2 0
Support another treatment 1 1
Elevated blood sugar (glucose) 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
2 100%

Dosages

  daily 200 mg daily 500 mg daily 1000 mg daily 2000 mg daily 2550 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 4 Number of Patients: 4 9 Number of Patients: 9 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Metformin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Personal research
1 33% Personal research: 33%
Doctor's advice
1 33% Doctor's advice: 33%
Side effects too severe
1 33% Side effects too severe: 33%

See all 3 patients who’ve stopped taking Metformin

Currently Taking Metformin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
2
2
4

Stopped Taking Metformin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
0
2

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.